PTG logo

Poltreg S.A. Stock Price

WSE:PTG Community·zł120.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

PTG Share Price Performance

zł25.80
-12.20 (-32.11%)
zł25.80
-12.20 (-32.11%)
Price zł25.80

PTG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

High growth potential with adequate balance sheet.

3 Risks
1 Reward

Poltreg S.A. Key Details

zł0

Revenue

zł5.5m

Cost of Revenue

-zł5.5m

Gross Profit

zł19.1m

Other Expenses

-zł24.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-5.27
0%
0%
0%
View Full Analysis

About PTG

Founded
2016
Employees
33
CEO
Piotr Trzonkowsk
WebsiteView website
poltreg.tech

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.

Recent PTG News & Updates

Recent updates

No updates